Skip to main content
. 2016 Jun 5;5(9):2171–2179. doi: 10.1002/cam4.774

Table 1.

Associations of patient demographic and tumor‐related characters with OS

Parameter Patients Death MST Univariate analysisa Multivariate analysisb
No. No. (months) HR (95% CI) P HR (95% CI) P
Age (years)
≤58 259 111 65.5 1.00 1.00
>58 257 123 57.6 1.16 (0.9–1.50) 0.254 1.28 (0.97–1.69) 0.079
Sex
Male 389 173 63.3 1.00 1.00
Female 127 61 46.7 1.07 (0.80–1.43) 0.657 1.08 (0.67–1.76) 0.752
Smoking status
Never 158 76 46.5 1.00 1.00
Ever 358 158 63.9 0.91 (0.69–1.20) 0.494 1.05 (0.65–1.69) 0.842
Alcohol intake
Never 311 139 61.6 1.00 1.00
Ever 205 95 57.7 0.98 (0.75–1.27) 0.871 0.99 (0.72–1.36) 0.946
Family history of cancer
No 440 202 59.1 1.00 1.00
Yes 76 32 NA 0.89 (0.61–1.29) 0.538 0.86 (0.58–1.27) 0.451
Histological types
Squamous Carcinoma 242 106 67.7 1.00 1.00
Adenocarcinoma 249 124 46.5 1.22 (0.94–1.58) 0.137 1.37 (0.99–1.89) 0.055
Others 25 4 NA 0.29 (0.11–0.79) 0.015 0.26 (0.06–1.09) 0.065
TNM stage
Ia 38 5 NA 1.00 1.00
Ib 87 23 NA 2.34 (0.89–6.16) 0.085 2.63 (0.99–6.99) 0.053
IIa 62 24 NA 3.78 (1.44–9.92) 0.007 4.2 (1.59–11.13) 0.004
IIb 63 26 NA 4.70 (1.80–12.24) 0.002 5.24 (1.98–13.87) 0.001
IIIa 168 102 23.3 8.35 (3.40–20.53) <.0001 8.68 (3.47–21.69) <.0001
IIIb 28 21 16 12.64 (4.75–33.64) <.0001 11.13 (4.07–30.48) <.0001
IV 39 26 17 10.74 (4.12–28.05) <.0001 10.21 (3.86–27.03) <.0001
Missing 31
Laterality
Left 236 117 41.9 1.00 1.00
Right 275 113 66.3 0.79 (0.61–1.03) 0.077 0.93 (0.71–1.22) 0.589
Others 5
Surgical approach
Lobectomy or sublobectomy 442 181 85.3 1.00 1.00
Pneumonectomy 74 53 18.6 2.56 (1.88–3.49) <.0001 1.82 (1.28–2.58) 0.001
Chemotherapyc
No 209 87 NA 1.00 1.00
Yes 307 147 48.9 1.07 (0.82–1.40) 0.613 0.87 (0.64–1.20) 0.398
Radiotherapyc
No 372 156 84.8 1.00 1.00
Yes 144 78 38.7 1.24 (0.95–1.63) 0.120 1.04 (0.75–1.44) 0.812
DNA source
Fresh 126 33 NA 1.00 1.00
FFPE 390 201 57.6 1.34 (0.92–1.95) 0.132 1.42 (0.97–2.09) 0.073

FFPE, formalin‐fixed paraffin‐embedded; MST, median survival time; OS, overall survival; HR, hazards ratio; 95% confidence interval, 95% CI; not available, NA.

a

univariate analysis.

b

Adjusted by other variables in Table 1.

c

Chemotherapy or Radiotherapy after operation.